ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683555 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683555; 2) Community: the network communities that were significantly associated with the response to NSC 683555; 3) Molecule: the relationships between components within communities and NSC 683555; 4) MDR: the compounds that were significantly associated with the NSC 683555.

NSC Compound Enrichment Correlation
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.0342636096654271 0.14217236
NSC 710716 Null 0.0342636096654271 0.27258731
NSC 720297 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate~ -3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spiro-1"-(4"-t-butyl)cyclohexane 0.0342636096654271 0.23153732
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0342636096654271 0.1897359
NSC 733504 Everolimus 0.0342636096654271 0.07315444
NSC 740 Methotrexate 0.0342636096654271 0.61797106
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0342636096654271 0.15738347
NSC 109834 Null 0.0342636096654276 0.34127509
NSC 117274 Null 0.0342636096654276 0.18461194
NSC 121713 Null 0.0342636096654276 0.29234283
Total:89  Current:63    [First] [Prev] [Next] [Last]